Olstech Tablet 20mg (Olmesartan Medoxomil)

Adult dose

The recommended initial dose is 10mg once daily, and it can be administered regardless of meal timing. If blood pressure is not adequately controlled, the dose can be increased to 20mg once daily. If additional blood pressure reduction is required, the dose can be increased up to a maximum of 40mg once daily. The antihypertensive effect will manifest within 2 weeks of starting treatment, and the maximum effect will occur after approximately 8 weeks. If hypertension is not adequately controlled with monotherapy, it can be combined with thiazide diuretics such as hydrochlorothiazide.

Child dose

Safety and efficacy in children have not been established.

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Persons with an allergy to this medication or its components, pregnant women, nursing mothers, patients undergoing kidney dialysis, patients with severe liver impairment, patients with bile duct obstruction, and patients with lactose intolerance should not take this medication. Hypotension may occur in patients with decreased blood volume or sodium levels, so their condition should be closely monitored, and appropriate measures should be taken if necessary. Patients with reduced kidney function or who have received a kidney transplant must periodically check kidney function and blood potassium levels through blood tests, and this medication is not recommended for those with severe renal impairment. Patients with hypertension, heart failure, kidney problems, etc., may experience side effects such as worsening of kidney function or hyperkalemia, so caution is needed. Dizziness may occur, so it is advisable to avoid hazardous activities such as working at heights or driving. If taken with other antihypertensive medications, the blood pressure-lowering effect may be increased, and combined use with potassium-sparing diuretics or potassium supplements may lead to dangerously elevated potassium levels in the blood. Concomitant use with lithium preparations can increase lithium concentrations, leading to toxicity; therefore, this combination should be avoided. Caution is required as the use of non-steroidal anti-inflammatory drugs (NSAIDs) may worsen kidney function. Pregnant women should discontinue use to avoid serious impacts on the fetus, and nursing mothers should discontinue breastfeeding or the medication due to the potential for adverse reactions in infants. Safety has not been established for children, so it is advisable not to use this medication in pediatric patients. In case of overdose, hypotension and palpitations may occur, so it is important to consult medical personnel immediately if any unusual symptoms arise. This medication is known to have a low risk of carcinogenicity or genotoxicity with long-term use; however, any unusual symptoms encountered during treatment should be reported to healthcare professionals immediately.

Serious side effects

Hives, severe swelling (edema), angioedema, chest tightness, difficulty breathing, anaphylaxis, cold sweat, pallor, severe rash with fever, blistering, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, abnormal liver function tests, sudden and severe headache, lightning-like pain

Mild side effects

• Dizziness
• headache
• palpitations
• hypercholesterolemia
• hyperlipidemia
• hyperuricemia
• joint pain
• arthritis
• myalgia
• rash

This medication may be sensitive to air and moisture, so it must be stored in a tightly closed container. It is best to maintain the storage temperature between 1 to 25 degrees Celsius to preserve its effectiveness for a long time.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle